ReviewInflammopharmacology2026

A new paradigm in Parkinson's disease: kidney-origin α-synuclein pathology driven by PKC signaling and aurothioglucose.

Kanika Vashisht et al.PubMed ↗Publisher ↗

No numbers read from the abstract.